ANI
is a Minnesota-based pharmaceutical company that develops and commercializes generic prescription medicines for the treatment of various diseases... Read moreANI
is a Minnesota-based pharmaceutical company that develops and commercializes generic prescription medicines for the treatment of various diseases... Read more
News
Regulatory
Mar 17, 2025
Pharmabiz
US FDA approves expanded label for ANI Pharma's Iluvien to treat chronic noninfectious uveitis affecting the posterior segment of the eye
Conference Presentation
Jan 28, 2025
Benzinga
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
Funding
Aug 14, 2024
GlobeNewswire
ANI received $316.3M in Post-IPO Debt Funding
Acquisition
Jun 24, 2024
BioSpace
ANI acquired Alimera Sciences, Inc. for $381M
ANI Competitors
1
2
3
4
5
6
7
8
9
10